Century Therapeutics, Inc.
IPSC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850119
In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.
Holders of 5% or more of IPSC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Century Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 13G/A | 6.80%5.96M shares | – | Feb 17, 20261 filing | Feb 17, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Century Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 20264:36 PM ET | Point72 Asset Management, L.P.and 2 others | 13G/A | 6.80%5.96M shares | – | Dec 23, 2025 | SEC |
| Nov 14, 20254:30 PM ET | Bain Capital Life Sciences Opportunities III, LP | 13G/A | 4.10%3.54M shares | –Below 5% | Sep 30, 2025 | SEC |
| May 15, 20254:27 PM ET | Casdin Capital, LLCand 1 other | 13G/A | 3.70%3.21M shares | –Below 5% | Mar 31, 2025 | SEC |
| Feb 14, 20256:14 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G/A | 4.70%3.96M shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Century Therapeutics, Inc. shares.
No Form 144 notices for Century Therapeutics, Inc. are on file.